European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 71

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 71

Pharmaceutical Technology

DECEMBER 14, 2022

Harrow has signed a binding agreement to acquire exclusive US commercial rights to five ophthalmic products of Novartis. These products, namely, Ilevro, Vigamox, Maxidex, Nevanac and Triesence, have received approval from the Food and Drug Administration (FDA).

Food and Drug Administration 59

Food and Drug Administration Pharmaceutical products FDA Marketing 59

European Pharmaceutical Review

JANUARY 9, 2024

Accelerated drug discovery: Simulations and predictive models powered by AI will speed up the drug development process, effectively slashing time to market for drugs. Internet] US Food and Drug Administration (FDA). Tuijin Jishu / Propuls. 2023; 44(3):1384-1392. cited 2023Dec]. N Engl J Med.

Pharmaceutical manufacturing 121

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 121

Pharmaceutical Representative Training

JUNE 22, 2024

Within this dynamic sales landscape, the significance of certified pharmaceutical representatives has grown alongside the industry’s increasingly complex form and regulation. Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Lack of proper training can lead to errors, omissions, or intentional data manipulation, which can compromise data.

Government 82

Government Pharma Ethics Training 82

European Pharmaceutical Review

APRIL 21, 2023

In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains. Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA).

Pharma 76

Pharma Food and Drug Administration Medicine Pharmaceutical 76

Cadensee

JULY 20, 2021

21:40 At what scale is breaking away from traditional channel to market is happening on a wide scale in the industry? 52:21 Uri's opinion about the main problem that needs to be solved for the healthcare market with technology. It might be silly question but bringing a drug to market takes many, many years.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52